• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Lynn Yoffee

Articles by Lynn Yoffee

Deals roundup: For $2M, St. Jude gets IP of Northstar Neuroscience

June 10, 2009
By Lynn Yoffee

Pacific's bladder cancer test may trim invasive cystoscopies

June 4, 2009
By Lynn Yoffee

Pacific's bladder cancer test may trim invasive cystoscopies

June 1, 2009
By Lynn Yoffee

BioCardia's Morph AccessPro is tool for PAD procedures

May 29, 2009
By Lynn Yoffee

Nanotech offers novel solutions for early cancer detection

May 28, 2009
By Lynn Yoffee
ATLANTA – Pancreatic and ovarian cancers are two of the deadliest forms of cancer, primarily due to the fact that they aren't diagnosed until late stages. Nanotechnology may offer some early detection solutions and the latest advances were reported at BIO 2009, the annual meeting of the Biotechnology Industry Organization (Washington). (Diagnostics & Imaging Week)
Read More

Nanotech offers novel solutions for early cancer detection

May 21, 2009
By Lynn Yoffee

Partnering with physicians is key to new test adoption

May 21, 2009
By Lynn Yoffee
ATLANTA – The reality in life sciences is that you need physician buy in for any new medical technology. The gee whiz factor just doesn't count unless the docs say "OK." That's the conundrum presented by the makers of non-invasive diagnostic tests: a potential boon for patients, but an economic slap for many physician practices. Strategies to overcome these challenges were addressed by a panel at BIO 2009, the annual meeting of the Biotechnology Industry Organization (Washington). (Diagnostics & Imaging Week)
Read More

Partnering with physicians is key to new test adoption

May 20, 2009
By Lynn Yoffee
ATLANTA — The reality in life sciences is that you need physician buy in for any new medical technology. The gee whiz factor just doesn't count unless the docs say "OK." (Medical Device Daily)
Read More

CoreSpine gets 510(k) clearance for disc tissue removal device

May 5, 2009
By Lynn Yoffee
Build a better surgical tool and, voila, a new med-tech company is born. That's the story behind four-year-old CoreSpine Technologies (Minneapolis), which just received FDA 510(k) clearance for its Xtend-ST Nucleus Removal System, a device intended to replace decades-old rongeurs when used for complete or selective removal of material from the lumbar disc space. (Medical Device Daily)
Read More

Lifelike surgical training models skirt the mess of cadavers, animals

May 1, 2009
By Lynn Yoffee
Previous 1 2 … 18 19 20 21 22 23 24 25 26 … 50 51 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 30, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 30, 2025.
  • 3d rendering of bispecific antibodies

    Pfizer bets $6B+ on 3Sbio’s bispecific PD-1/VEGF antibody

    BioWorld
    Pfizer Inc. is paying $1.25 billion up front and up to $4.8 billion in milestone payments to gain global, ex-China rights to SSGJ-707, a PD-1/VEGF bispecific...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 27, 2025
  • KT-621: a first-in-class STAT6 degrader for Th2-driven diseases

    BioWorld Science
    STAT6 plays a central role in regulating Th2-driven immune responses. Recent studies have identified gain-of-function mutations in the STAT6 gene that are...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe